Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD) : Investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology
This study introduces a laboratory model of compulsive behavior based on persistence in the context of rewarded spatial alternation. Rats were screened for spontaneous persistence during T-maze reinforced alternation. Experiment 1: One high and one low spontaneous persistence group (n = 8) received...
Gespeichert in:
Veröffentlicht in: | Biological psychiatry (1969) 2005-05, Vol.57 (10), p.1176-1185 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1185 |
---|---|
container_issue | 10 |
container_start_page | 1176 |
container_title | Biological psychiatry (1969) |
container_volume | 57 |
creator | TSALTAS, Eleftheria KONTIS, Dimitris CHRYSIKAKOU, Sofia GIANNOU, Haralambos BIBA, Angeliki PALLIDI, Stella CHRISTODOULOU, Angeliki MAILLIS, Antonis RABAVILAS, Andreas |
description | This study introduces a laboratory model of compulsive behavior based on persistence in the context of rewarded spatial alternation.
Rats were screened for spontaneous persistence during T-maze reinforced alternation. Experiment 1: One high and one low spontaneous persistence group (n = 8) received 20 injections of fluoxetine, a matched pair saline, both followed by 4 days of meta-chlorophenylpiperazine (mCPP) challenge. Experiment 2: Five matched groups of rats (n = 9) received pretreatment (20 injections) with fluoxetine, mCPP, desipramine, diazepam or saline, followed by 4 days of mCPP challenge (fluoxetine in mCPP group). After washout, animals received 2 days of naratriptan, followed by another 2-day mCPP challenge.
In both experiments mCPP significantly increased persistence in saline controls. Fluoxetine also acutely increased persistence scores: after a gradual return to baseline, these scores showed tolerance to mCPP. Experiment 1: This pattern was significant in high but not low initial persistence groups. Experiment 2: Fluoxetine and mCPP showed cross-tolerance. Neither desipramine nor diazepam protected against mCPP challenge. Persistence scores returned to baseline during washout and naratriptan and were thereafter increased by another mCPP challenge in all but the fluoxetine and mCPP groups, suggesting 5-HT2C receptor mediation.
This model is based on spontaneous persistence behavior showing pharmacological responses concordant with those of compulsive symptomatology. |
doi_str_mv | 10.1016/j.biopsych.2005.02.020 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67788868</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67788868</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-d3618c3938bfc1f2e653dd2c7878a89c5eaedd705bb06020217e6d6ba6153f403</originalsourceid><addsrcrecordid>eNpFUU1vEzEQ3QOoLS1_ofIFBIcN_sBehxtKgVaqVKkqZ8trzzaOvPbi2UTKT-Jf1iFBlUb2G_nNm_G8prlmdMEoU182iz7kCfduveCUygXlNeib5oJSqlrBuThv3iFuatpxzs6acya1UlLqi-bvI4Q05OLAE5zsHGwkNs5QUsU5EYvE1jOFsT6M2UMkeSC5R0AMO2hdHqdtPEDiA-bioZBPD6ubz-QbuUs7wDk8H5VqmWxvn_iqqvl_kN2QAg6mORcS0i7HHYyQ5opJVSB1mnWe1nsMOebn_VXzdrAR4f3pvmx-__zxtLpt7x9-3a2-37dOiOXceqGYdmIpdD84NnBQUnjPXac7bfXSSbDgfUdl31NV18RZB8qr3iomxfCVisvm41F3KvnPtn7AjAEdxGgT5C0a1XVaa6UrUR2JrmTEAoOZSl1T2RtGzcEYszH_jTEHYwzlNQ4drk8dtv0I_rXs5EolfDgRLDobh2KTC_jKU3UCQal4AQntnWA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67788868</pqid></control><display><type>article</type><title>Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD) : Investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>TSALTAS, Eleftheria ; KONTIS, Dimitris ; CHRYSIKAKOU, Sofia ; GIANNOU, Haralambos ; BIBA, Angeliki ; PALLIDI, Stella ; CHRISTODOULOU, Angeliki ; MAILLIS, Antonis ; RABAVILAS, Andreas</creator><creatorcontrib>TSALTAS, Eleftheria ; KONTIS, Dimitris ; CHRYSIKAKOU, Sofia ; GIANNOU, Haralambos ; BIBA, Angeliki ; PALLIDI, Stella ; CHRISTODOULOU, Angeliki ; MAILLIS, Antonis ; RABAVILAS, Andreas</creatorcontrib><description>This study introduces a laboratory model of compulsive behavior based on persistence in the context of rewarded spatial alternation.
Rats were screened for spontaneous persistence during T-maze reinforced alternation. Experiment 1: One high and one low spontaneous persistence group (n = 8) received 20 injections of fluoxetine, a matched pair saline, both followed by 4 days of meta-chlorophenylpiperazine (mCPP) challenge. Experiment 2: Five matched groups of rats (n = 9) received pretreatment (20 injections) with fluoxetine, mCPP, desipramine, diazepam or saline, followed by 4 days of mCPP challenge (fluoxetine in mCPP group). After washout, animals received 2 days of naratriptan, followed by another 2-day mCPP challenge.
In both experiments mCPP significantly increased persistence in saline controls. Fluoxetine also acutely increased persistence scores: after a gradual return to baseline, these scores showed tolerance to mCPP. Experiment 1: This pattern was significant in high but not low initial persistence groups. Experiment 2: Fluoxetine and mCPP showed cross-tolerance. Neither desipramine nor diazepam protected against mCPP challenge. Persistence scores returned to baseline during washout and naratriptan and were thereafter increased by another mCPP challenge in all but the fluoxetine and mCPP groups, suggesting 5-HT2C receptor mediation.
This model is based on spontaneous persistence behavior showing pharmacological responses concordant with those of compulsive symptomatology.</description><identifier>ISSN: 0006-3223</identifier><identifier>DOI: 10.1016/j.biopsych.2005.02.020</identifier><identifier>PMID: 15866558</identifier><identifier>CODEN: BIPCBF</identifier><language>eng</language><publisher>New York, NY: Elsevier Science</publisher><subject>Animals ; Anti-Anxiety Agents - pharmacology ; Antidepressive Agents, Tricyclic - pharmacology ; Behavioral psychophysiology ; Biological and medical sciences ; Desipramine - pharmacology ; Diazepam - pharmacology ; Disease Models, Animal ; Fluoxetine - pharmacology ; Fundamental and applied biological sciences. Psychology ; Indoles - pharmacology ; Male ; Maze Learning - physiology ; Miscellaneous ; Obsessive-Compulsive Disorder - physiopathology ; Obsessive-Compulsive Disorder - psychology ; Piperazines - pharmacology ; Piperidines - pharmacology ; Psychology. Psychoanalysis. Psychiatry ; Psychology. Psychophysiology ; Rats ; Rats, Wistar ; Receptor, Serotonin, 5-HT1D - physiology ; Receptor, Serotonin, 5-HT2C - physiology ; Reinforcement (Psychology) ; Serotonin Receptor Agonists - pharmacology ; Serotonin Uptake Inhibitors - pharmacology ; Tryptamines</subject><ispartof>Biological psychiatry (1969), 2005-05, Vol.57 (10), p.1176-1185</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-d3618c3938bfc1f2e653dd2c7878a89c5eaedd705bb06020217e6d6ba6153f403</citedby><cites>FETCH-LOGICAL-c339t-d3618c3938bfc1f2e653dd2c7878a89c5eaedd705bb06020217e6d6ba6153f403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16788300$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15866558$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TSALTAS, Eleftheria</creatorcontrib><creatorcontrib>KONTIS, Dimitris</creatorcontrib><creatorcontrib>CHRYSIKAKOU, Sofia</creatorcontrib><creatorcontrib>GIANNOU, Haralambos</creatorcontrib><creatorcontrib>BIBA, Angeliki</creatorcontrib><creatorcontrib>PALLIDI, Stella</creatorcontrib><creatorcontrib>CHRISTODOULOU, Angeliki</creatorcontrib><creatorcontrib>MAILLIS, Antonis</creatorcontrib><creatorcontrib>RABAVILAS, Andreas</creatorcontrib><title>Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD) : Investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology</title><title>Biological psychiatry (1969)</title><addtitle>Biol Psychiatry</addtitle><description>This study introduces a laboratory model of compulsive behavior based on persistence in the context of rewarded spatial alternation.
Rats were screened for spontaneous persistence during T-maze reinforced alternation. Experiment 1: One high and one low spontaneous persistence group (n = 8) received 20 injections of fluoxetine, a matched pair saline, both followed by 4 days of meta-chlorophenylpiperazine (mCPP) challenge. Experiment 2: Five matched groups of rats (n = 9) received pretreatment (20 injections) with fluoxetine, mCPP, desipramine, diazepam or saline, followed by 4 days of mCPP challenge (fluoxetine in mCPP group). After washout, animals received 2 days of naratriptan, followed by another 2-day mCPP challenge.
In both experiments mCPP significantly increased persistence in saline controls. Fluoxetine also acutely increased persistence scores: after a gradual return to baseline, these scores showed tolerance to mCPP. Experiment 1: This pattern was significant in high but not low initial persistence groups. Experiment 2: Fluoxetine and mCPP showed cross-tolerance. Neither desipramine nor diazepam protected against mCPP challenge. Persistence scores returned to baseline during washout and naratriptan and were thereafter increased by another mCPP challenge in all but the fluoxetine and mCPP groups, suggesting 5-HT2C receptor mediation.
This model is based on spontaneous persistence behavior showing pharmacological responses concordant with those of compulsive symptomatology.</description><subject>Animals</subject><subject>Anti-Anxiety Agents - pharmacology</subject><subject>Antidepressive Agents, Tricyclic - pharmacology</subject><subject>Behavioral psychophysiology</subject><subject>Biological and medical sciences</subject><subject>Desipramine - pharmacology</subject><subject>Diazepam - pharmacology</subject><subject>Disease Models, Animal</subject><subject>Fluoxetine - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Indoles - pharmacology</subject><subject>Male</subject><subject>Maze Learning - physiology</subject><subject>Miscellaneous</subject><subject>Obsessive-Compulsive Disorder - physiopathology</subject><subject>Obsessive-Compulsive Disorder - psychology</subject><subject>Piperazines - pharmacology</subject><subject>Piperidines - pharmacology</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychology. Psychophysiology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptor, Serotonin, 5-HT1D - physiology</subject><subject>Receptor, Serotonin, 5-HT2C - physiology</subject><subject>Reinforcement (Psychology)</subject><subject>Serotonin Receptor Agonists - pharmacology</subject><subject>Serotonin Uptake Inhibitors - pharmacology</subject><subject>Tryptamines</subject><issn>0006-3223</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFUU1vEzEQ3QOoLS1_ofIFBIcN_sBehxtKgVaqVKkqZ8trzzaOvPbi2UTKT-Jf1iFBlUb2G_nNm_G8prlmdMEoU182iz7kCfduveCUygXlNeib5oJSqlrBuThv3iFuatpxzs6acya1UlLqi-bvI4Q05OLAE5zsHGwkNs5QUsU5EYvE1jOFsT6M2UMkeSC5R0AMO2hdHqdtPEDiA-bioZBPD6ubz-QbuUs7wDk8H5VqmWxvn_iqqvl_kN2QAg6mORcS0i7HHYyQ5opJVSB1mnWe1nsMOebn_VXzdrAR4f3pvmx-__zxtLpt7x9-3a2-37dOiOXceqGYdmIpdD84NnBQUnjPXac7bfXSSbDgfUdl31NV18RZB8qr3iomxfCVisvm41F3KvnPtn7AjAEdxGgT5C0a1XVaa6UrUR2JrmTEAoOZSl1T2RtGzcEYszH_jTEHYwzlNQ4drk8dtv0I_rXs5EolfDgRLDobh2KTC_jKU3UCQal4AQntnWA</recordid><startdate>20050515</startdate><enddate>20050515</enddate><creator>TSALTAS, Eleftheria</creator><creator>KONTIS, Dimitris</creator><creator>CHRYSIKAKOU, Sofia</creator><creator>GIANNOU, Haralambos</creator><creator>BIBA, Angeliki</creator><creator>PALLIDI, Stella</creator><creator>CHRISTODOULOU, Angeliki</creator><creator>MAILLIS, Antonis</creator><creator>RABAVILAS, Andreas</creator><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050515</creationdate><title>Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD) : Investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology</title><author>TSALTAS, Eleftheria ; KONTIS, Dimitris ; CHRYSIKAKOU, Sofia ; GIANNOU, Haralambos ; BIBA, Angeliki ; PALLIDI, Stella ; CHRISTODOULOU, Angeliki ; MAILLIS, Antonis ; RABAVILAS, Andreas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-d3618c3938bfc1f2e653dd2c7878a89c5eaedd705bb06020217e6d6ba6153f403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Anti-Anxiety Agents - pharmacology</topic><topic>Antidepressive Agents, Tricyclic - pharmacology</topic><topic>Behavioral psychophysiology</topic><topic>Biological and medical sciences</topic><topic>Desipramine - pharmacology</topic><topic>Diazepam - pharmacology</topic><topic>Disease Models, Animal</topic><topic>Fluoxetine - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Indoles - pharmacology</topic><topic>Male</topic><topic>Maze Learning - physiology</topic><topic>Miscellaneous</topic><topic>Obsessive-Compulsive Disorder - physiopathology</topic><topic>Obsessive-Compulsive Disorder - psychology</topic><topic>Piperazines - pharmacology</topic><topic>Piperidines - pharmacology</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychology. Psychophysiology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptor, Serotonin, 5-HT1D - physiology</topic><topic>Receptor, Serotonin, 5-HT2C - physiology</topic><topic>Reinforcement (Psychology)</topic><topic>Serotonin Receptor Agonists - pharmacology</topic><topic>Serotonin Uptake Inhibitors - pharmacology</topic><topic>Tryptamines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TSALTAS, Eleftheria</creatorcontrib><creatorcontrib>KONTIS, Dimitris</creatorcontrib><creatorcontrib>CHRYSIKAKOU, Sofia</creatorcontrib><creatorcontrib>GIANNOU, Haralambos</creatorcontrib><creatorcontrib>BIBA, Angeliki</creatorcontrib><creatorcontrib>PALLIDI, Stella</creatorcontrib><creatorcontrib>CHRISTODOULOU, Angeliki</creatorcontrib><creatorcontrib>MAILLIS, Antonis</creatorcontrib><creatorcontrib>RABAVILAS, Andreas</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biological psychiatry (1969)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TSALTAS, Eleftheria</au><au>KONTIS, Dimitris</au><au>CHRYSIKAKOU, Sofia</au><au>GIANNOU, Haralambos</au><au>BIBA, Angeliki</au><au>PALLIDI, Stella</au><au>CHRISTODOULOU, Angeliki</au><au>MAILLIS, Antonis</au><au>RABAVILAS, Andreas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD) : Investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology</atitle><jtitle>Biological psychiatry (1969)</jtitle><addtitle>Biol Psychiatry</addtitle><date>2005-05-15</date><risdate>2005</risdate><volume>57</volume><issue>10</issue><spage>1176</spage><epage>1185</epage><pages>1176-1185</pages><issn>0006-3223</issn><coden>BIPCBF</coden><abstract>This study introduces a laboratory model of compulsive behavior based on persistence in the context of rewarded spatial alternation.
Rats were screened for spontaneous persistence during T-maze reinforced alternation. Experiment 1: One high and one low spontaneous persistence group (n = 8) received 20 injections of fluoxetine, a matched pair saline, both followed by 4 days of meta-chlorophenylpiperazine (mCPP) challenge. Experiment 2: Five matched groups of rats (n = 9) received pretreatment (20 injections) with fluoxetine, mCPP, desipramine, diazepam or saline, followed by 4 days of mCPP challenge (fluoxetine in mCPP group). After washout, animals received 2 days of naratriptan, followed by another 2-day mCPP challenge.
In both experiments mCPP significantly increased persistence in saline controls. Fluoxetine also acutely increased persistence scores: after a gradual return to baseline, these scores showed tolerance to mCPP. Experiment 1: This pattern was significant in high but not low initial persistence groups. Experiment 2: Fluoxetine and mCPP showed cross-tolerance. Neither desipramine nor diazepam protected against mCPP challenge. Persistence scores returned to baseline during washout and naratriptan and were thereafter increased by another mCPP challenge in all but the fluoxetine and mCPP groups, suggesting 5-HT2C receptor mediation.
This model is based on spontaneous persistence behavior showing pharmacological responses concordant with those of compulsive symptomatology.</abstract><cop>New York, NY</cop><pub>Elsevier Science</pub><pmid>15866558</pmid><doi>10.1016/j.biopsych.2005.02.020</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-3223 |
ispartof | Biological psychiatry (1969), 2005-05, Vol.57 (10), p.1176-1185 |
issn | 0006-3223 |
language | eng |
recordid | cdi_proquest_miscellaneous_67788868 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Animals Anti-Anxiety Agents - pharmacology Antidepressive Agents, Tricyclic - pharmacology Behavioral psychophysiology Biological and medical sciences Desipramine - pharmacology Diazepam - pharmacology Disease Models, Animal Fluoxetine - pharmacology Fundamental and applied biological sciences. Psychology Indoles - pharmacology Male Maze Learning - physiology Miscellaneous Obsessive-Compulsive Disorder - physiopathology Obsessive-Compulsive Disorder - psychology Piperazines - pharmacology Piperidines - pharmacology Psychology. Psychoanalysis. Psychiatry Psychology. Psychophysiology Rats Rats, Wistar Receptor, Serotonin, 5-HT1D - physiology Receptor, Serotonin, 5-HT2C - physiology Reinforcement (Psychology) Serotonin Receptor Agonists - pharmacology Serotonin Uptake Inhibitors - pharmacology Tryptamines |
title | Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD) : Investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T05%3A16%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reinforced%20spatial%20alternation%20as%20an%20animal%20model%20of%20obsessive-compulsive%20disorder%20(OCD)%20:%20Investigation%20of%205-HT2C%20and%205-HT1D%20receptor%20involvement%20in%20OCD%20pathophysiology&rft.jtitle=Biological%20psychiatry%20(1969)&rft.au=TSALTAS,%20Eleftheria&rft.date=2005-05-15&rft.volume=57&rft.issue=10&rft.spage=1176&rft.epage=1185&rft.pages=1176-1185&rft.issn=0006-3223&rft.coden=BIPCBF&rft_id=info:doi/10.1016/j.biopsych.2005.02.020&rft_dat=%3Cproquest_cross%3E67788868%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67788868&rft_id=info:pmid/15866558&rfr_iscdi=true |